AnGes’ Lonafarnib Granted Orphan Drug Designation by Japanese Ministry of Health for HGPS Treatment
Anges Inc. announced that Lonafarnib (marketed in the US as Zokinvy), a medication designed to treat Hutchinson-Gilford Progeria Syndrome (HGPS) and Processing-Deficient Progeroid Laminopathy (PL), ha ...